SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

A speculative, community-led meme-coin push is driving attention, with traders highlighting 4CHANs recent resilience and apparent outperformance while broader crypto markets weaken, alongside claims about its large supply, locked liquidity, and 4chan meme-culture branding. Skeptics counter that the move could be a pump-and-dump and question the tokens liquidity and economics.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A bearish short report from BMF focused on SELLASs REGAL Phase 3 trial, questioning its statistical power, historical controls, and valuation, triggered the sharp selloff and intensified debate ahead of the 80th-event announcement and topline results. Bulls argue the report misinterprets the trial design and point to prolonged patient survival and prior independent monitoring, while bears remain concerned that the study could be underpowered or fail its endpoint.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Treasury Secretary Scott Bessents expanded long-term Treasury buyback plan and potential use of Treasury cash to support the bond market are driving attention to TLT amid elevated long-end yields. Traders are divided: some expect government intervention and a bond short squeeze to push yields lower, while others argue persistent inflation, heavy borrowing and a potentially hawkish Fed will overwhelm the buybacks and keep pressure on long-duration bonds.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

A strong second-quarter beat and raised full-year outlook, combined with rotation into defensive healthcare stocks, is driving bullish attention around JNJ and its move near record highs. Traders are also speculatingwithout a confirmed agreementthat J&J could acquire oncology biotech Sellas to bolster its cancer portfolio.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

A favorable earnings reaction and the appointment of Disney-linked CEO Alisa Bowen are driving renewed interest, with traders betting on improved execution, lower content costs and closer Disney/streaming integration. Bullish participants are emphasizing short interest, accumulation and possible short covering, while skeptics point to weak volume, valuation, dilution concerns and execution risk.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswaps UNIfication governance proposalcentered on activating protocol fees and introducing substantial UNI burnsis driving attention, with traders expecting improved value capture and a more deflationary supply. The Robinhood integration adds to the bullish narrative, although some community members question the proposals status and remain bearish on the price action.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

Higher Treasury yields and renewed Federal Reserve rate-hike fears are driving a broad biotech selloff, with traders noting XBIs greater sensitivity to discount rates and financing risk. Some view the decline as a technical pullback and buying opportunity, while others expect sustained pressure if rates remain elevated.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

A volatile rebound alongside broader crypto strength, particularly Bitcoin, has driven attention to Dogecoin, with traders citing bullish technical momentum and renewed buying. The community remains divided over whether the move can extend or is a temporary pump headed for another pullback; speculation about renewed Elon-related support is secondary and unconfirmed.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

A broader rebound in software and SaaS stockslinked by traders to reports that Silver Lake may acquire Workdayhas lifted Adobe alongside peers. The community remains divided between bullish views that AI fears are overdone and Adobe is undervalued, and bearish concerns about AI-native competitors, valuation, and weakness ahead of earnings.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It operates through the following segments: Uranium, Rare Earth Elements (REE), and Heavy Mineral Sands (HMS). The uranium segment engages in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties along with the exploration, permitting and evaluation of uranium properties in the U.S. The REE segment is engaged in the company’s initiatives to progress towards full REE separation capabilities at the Mill to produce both light and heavy separated REE oxides in the coming years. The HMS segment engages in the exploration, development and recovery of HMS at the Kwale Project, Bahia Project, Vara Mada Project and the company’s equity method investments in the Donald Project JV and Tate. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels completed and approved acquisition of Australian Strategic Materials is driving attention, with traders focused on the added Korean Metals Plant capacity and the companys planned Western mine-to-magnet rare-earth supply chain alongside its uranium business. Bulls view the integration and recent heavy rare-earth milestones as strategic progress, while bears remain focused on weak price action, execution risk, and persistent selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600

Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire NEW YORK, May 7, 2026 NEW...

Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics

The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +139.30% and +33.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 52-Week High - Here's What Happened

Apellis Pharmaceuticals (NASDAQ:APLS) Sets New 12-Month High - What's Next...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Recommendation of "Hold" from Analysts

Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have been assigned an average recommendation of "Hold" from the twenty-three ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eighteen have...

Top 3 Health Care Stocks That May Collapse This Month

Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...

Pictet Asset Management Holding SA Has $9.84 Million Stock Holdings in Apellis Pharmaceuticals, Inc. $APLS

Pictet Asset Management Holding SA grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 390,884 shares of the company's stock after acquiring an...

UBS Group AG Boosts Stake in Apellis Pharmaceuticals, Inc. $APLS

UBS Group AG raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 22.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,186,222 shares of the company's stock after purchasing an additio...

Jennison Associates LLC Reduces Holdings in Apellis Pharmaceuticals, Inc. $APLS

Jennison Associates LLC cut its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 65.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,504,299 shares of the company's stock after selling 2,843...

• Reported GAAP EPS of -$0.47 down -62.07% YoY
• Reported revenue of $199.91M down -5.94% YoY
• Apellis Pharmaceuticals Inc. anticipates its cash and cash equivalents, combined with projected sales from EMPAVELI and SYFOVRE, will fund operating expenses and capital expenditures for at least the next 12 months.

Apellis Pharmaceuticals Inc. faces ongoing losses and significant competition, alongside regulatory uncertainties that could delay approvals and limit market acceptance of its key products.

Apellis Pharmaceuticals Inc. has successfully commercialized two key drugs, is advancing its pipeline with next-generation therapies, and initiated pivotal trials for EMPAVELI in rare nephrology conditions.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info